Reparixin in Patients With Myelofibrosis Myeloproliferative Neoplasms Research Consortium (MPN-RC 120)

Clinical trial NCT05835466 · RECRUITING

Trial details

NCT number: NCT05835466
Sponsor: Icahn School of Medicine at Mount Sinai
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Myelofibrosis (PMF)Post Essential Thrombocythemia Myelofibrosis (ET-MF)Post Polycythemia Vera Related Myelofibrosis (PV-MF)

Start date: 2023-07-24
Primary completion: 2027-12-31
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.